PATHOGENESIS AND TREATMENT OF PRETIBIAL MYXEDEMA

被引：65

作者：

KRISS, JP

机构：

[1] STANFORD UNIV HOSP,STANFORD,CA 94305

[2] STANFORD UNIV,MED CTR,SCH MED,DEPT DIAGNOST RADIOL,DIV NUCL MED,STANFORD,CA 94305

[3] STANFORD UNIV,MED CTR,SCH MED,DEPT NUCL MED,STANFORD,CA 94305

[4] VET ADM MED CTR,PALO ALTO,CA 94304

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 1987年 / 16卷 / 02期

关键词：

D O I：

10.1016/S0889-8529(18)30486-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：409 / 415

页数：7

共 31 条

[1]

ASAGAMI C, 1972, JPN J DERMATOL, V82, P694

[2] CORTICOID THERAPY FOR PRETIBIAL MYXEDEMA - OBSERVATIONS ON LONG-ACTING THYROID STIMULATOR [J].

BENOIT, FL ;

GREENSPA.FS .

ANNALS OF INTERNAL MEDICINE, 1967, 66 (04) :711-+

[3]

BIOULAC P, 1977, J CUTAN PATHOL, V4, P204

[4] STIMULATION OF FIBROBLAST BIOSYNTHETIC ACTIVITY BY SERUM OF PATIENTS WITH PRETIBIAL MYXEDEMA [J].

CHEUNG, HS ;

NICOLOFF, JT ;

KAMIEL, MB ;

SPOLTER, L ;

NIMNI, ME .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 71 (01) :12-17

[5]

DANDONA P, 1979, BRIT MED J, V1, P374, DOI 10.1136/bmj.1.6160.374

[6]

FUJITA H, 1971, ACTA PATHOL JAPON, V21, P207

[7] PRETIBIAL MYXEDEMA (ELEPHANTIASIC FORM) - TREATMENT WITH CYTO-TOXIC THERAPY [J].

HANKE, CW ;

BERGFELD, WF ;

GUIRGUIS, MN ;

LEWIS, LJ .

CLEVELAND CLINIC QUARTERLY, 1983, 50 (02) :183-188

[8] SERUM LONG-ACTING THYROID-STIMULATOR (LATS) AND LATS-PROTECTOR (LATS-P) IN GRAVES-DISEASE ASSOCIATED WITH LOCALIZED MYXEDEMA [J].

HARDISTY, CA ;

FOWLES, A ;

MUNRO, DS .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (02) :151-155

[9] AN ULTRASTRUCTURAL-STUDY OF PRETIBIAL MYXEDEMA UTILIZING IMPROVED RUTHENIUM RED STAIN [J].

ISHII, M ;

NAKAGAWA, K ;

HAMADA, T .

JOURNAL OF CUTANEOUS PATHOLOGY, 1984, 11 (02) :125-131

[10]

KOBAYASI T, 1976, ACTA DERM-VENEREOL, V56, P173

← 1 2 3 4 →